Nicotine Pouches as Medicine: What Canada, Australia, France, and Brazil Reveal About the Pharmaceutical Classification Model

News, RegulationsLeave a comment

As governments consider how to regulate nicotine pouches, one model is becoming increasingly important: treating oral nicotine products not as general consumer goods, but as medicines, natural health products, poisons, or pharmaceutical-style nicotine replacement therapies. This approach is most clearly visible in Canada, where Zonnic has become the leading example of a nicotine pouch authorised…

What Existing Nicotine Frameworks Can Teach Europe

News, RegulationsLeave a comment

While the European Union does not currently have a dedicated framework for modern nicotine products, several jurisdictions have already developed regulatory approaches that provide useful reference points for policymakers. These examples demonstrate that nicotine products can be regulated through frameworks that balance consumer protection, product oversight, youth safeguards, and adult access without relying solely on…

Nicotine Analogs and the Next Regulatory Challenge

News, RegulationsLeave a comment

The global nicotine landscape continues to evolve at a rapid pace. Over the past decade, regulators have focused primarily on traditional tobacco products, vaping devices, heated tobacco products, nicotine pouches, and synthetic nicotine. However, a new category is beginning to attract attention from policymakers, scientists, and public health stakeholders: nicotine analogs. While nicotine analogs remain…

France’s Nicotine Pouch Ban and Sweden’s Response: A Growing Debate Over Risk-Proportionate Regulation

News, RegulationsLeave a comment

The decision by France to prohibit nicotine pouches has triggered renewed debate across Europe about the future of nicotine regulation, the role of harm reduction, and the principles that should guide public health policy. While French authorities have justified the measure as a response to concerns surrounding youth uptake and nicotine addiction, the ban has…

UK Advertising Restrictions for Nicotine Products: What Stakeholders Should Watch Before June 2027

News, RegulationsLeave a comment

The United Kingdom has formally begun the next phase of its tobacco and nicotine regulatory transition. Following Royal Assent of the Tobacco and Vapes Act on 29 April 2026, the Department of Health and Social Care (DHSC) has confirmed that new advertising and sponsorship restrictions covering vaping products, nicotine pouches, herbal smoking products, and related…

Flavor Regulation and the Future of Nicotine Governance

Regulations, UncategorizedLeave a comment

Flavor regulation has become one of the most contested areas in modern nicotine policy. Across the United States, Europe, and global markets at varying stages of regulatory maturity, governments continue debating whether restrictions on flavored nicotine products represent an effective public health intervention or whether overly simplified approaches risk generating consequences their architects did not…

A Milestone in Evidence-Based Nicotine Regulation: FDA’s Environmental Assessment for Nicotine Pouches

News, RegulationsLeave a comment

The U.S. Food and Drug Administration’s recent programmatic environmental assessment for nicotine pouch products may represent one of the more important yet underexamined developments in modern nicotine regulation. While much public attention surrounding nicotine governance focuses on toxicology, youth access, and population health outcomes, the FDA’s latest findings introduce another increasingly relevant dimension into the…

Brazil’s 4mg Pharmaceutical Model: What ANVISA’s Direction Could Mean for Innovation, Consumers, and Latin America’s Regulatory Future

News, RegulationsLeave a comment

Brazil is increasingly positioning itself as one of Latin America’s most consequential regulatory bellwethers in the debate over novel nicotine products. As policymakers across the region assess how emerging nicotine categories should be governed, Brazil’s pharmaceutical-style approach, centered around strict dosage controls such as a 4mg cap, signals a distinctly cautious pathway. For GINN LatAm,…

Portugal’s Challenge to the UK Tobacco Ban: A New Test for Post-Brexit Regulatory Sovereignty

News, RegulationsLeave a comment

Portugal’s recent accusation that the United Kingdom’s proposed tobacco ban may violate post-Brexit legal commitments has introduced a new dimension into nicotine and tobacco policy debate, one that extends beyond domestic public health objectives and into the increasingly complex intersection of sovereignty, trade law, and international regulatory coherence. While the immediate issue centers on tobacco…

Nicotine Analogs and the Next Regulatory Frontier: Emerging Questions for Science, Policy, and Product Governance

News, RegulationsLeave a comment

Inspired by commentary from Chris Allen on discussions surrounding the 10th Keller and Heckman Symposium. As global nicotine regulation continues to evolve, one of the more technically complex and strategically significant emerging issues is the rise of nicotine analogs, compounds structurally related to nicotine that may increasingly challenge existing regulatory definitions, product classifications, and enforcement…